Showing results (101-110 of 215) with videos related to

Sort By:
Pageof 22
International Journal of Molecular Sciences|March 6, 2021
<i>N</i>-(1,3,4-Oxadiazol-2-yl)Benzamides as Antibacterial Agents against <i>Neisseria gonorrhoeae</i>George A Naclerio, Nader S Abutaleb, Marwa Alhashimi, et al.
Nucleic Acids Research|January 3, 2012
A rapid assay for affinity and kinetics of molecular interactions with nucleic acidsGregory P Donaldson, Kevin G Roelofs, Yiling Luo, et al.
Chemmedchem|April 3, 2018
Alkynylnicotinamide-Based Compounds as ABL1 Inhibitors with Potent Activities against Drug-Resistant CML Harboring ABL1(T315I) Mutant KinaseElizabeth A Larocque, N Naganna, Clement Opoku-Temeng, et al.
Future Medicinal Chemistry|April 16, 2015
Biofilm formation mechanisms and targets for developing antibiofilm agentsNira Rabin, Yue Zheng, Clement Opoku-Temeng, et al.
Organic Letters|June 21, 2017
Synthesis of (-)-6,7-Dideoxysqualestatin H5 by Carbonyl Ylide Cycloaddition-Rearrangement and Cross-electrophile CouplingYounes Fegheh-Hassanpour, Tanzeel Arif, Herman O Sintim, et al.
RSC Medicinal Chemistry|January 22, 2021
Potent trifluoromethoxy, trifluoromethylsulfonyl, trifluoromethylthio and pentafluorosulfanyl containing (1,3,4-oxadiazol-2-yl)benzamides against drug-resistant Gram-positive bacteriaGeorge A Naclerio, Nader S Abutaleb, Kenneth I Onyedibe, et al.
Chemical Communications (Cambridge, England)|November 12, 2009
Biological screening of a diverse set of AI-2 analogues in Vibrio harveyi suggests that receptors which are involved in synergistic agonism of AI-2 and analogues are promiscuousJacqueline A I Smith, Jingxin Wang, Sao-Mai Nguyen-Mau, et al.
Cytotechnology|October 19, 2016
Construction and characterization of a multilayered gingival keratinocyte culture model: the TURK-U modelUlvi K Gursoy, Mervi Gursoy, Eija Könönen, et al.
ACS Infectious Diseases|March 17, 2022
Comparative Studies to Uncover Mechanisms of Action of <i>N</i>-(1,3,4-Oxadiazol-2-yl)benzamide Containing Antibacterial AgentsGeorge A Naclerio, Kenneth I Onyedibe, Caroline W Karanja, et al.
RSC Medicinal Chemistry|January 29, 2024
Discovery of imidazo[1,2-<i>b</i>]pyridazine-containing TAK1 kinase inhibitors with excellent activities against multiple myelomaDesmond Akwata, Allison L Kempen, Jones Lamptey, et al.
Pageof 22